Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Pre-Tax Income
$72.5m
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$17.6B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
-$6.9B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Pre-Tax Income
$3.9B
CAGR 3-Years
-43%
CAGR 5-Years
-3%
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$13.7B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
7%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$10.2B
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
12%

See Also

What is Supernus Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
72.5m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Pre-Tax Income amounts to 72.5m USD.

What is Supernus Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-13%

Over the last year, the Pre-Tax Income growth was 96%. The average annual Pre-Tax Income growth rates for Supernus Pharmaceuticals Inc have been -13% over the past three years , -13% over the past five years .

Back to Top